Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Trimetazidine

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 136Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Martin Pharmaceuticals Receives FDA Orphan Drug Designation for LIVANTRA™
    Martin Pharmaceuticals Receives FDA Orphan Drug Designation for LIVANTRA™

    29 Mar 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180329005144/en/Martin-Pharmaceuticals-Receives-FDA-Orphan-Drug-Designation

    BUSINESSWIRE
    29 Mar 2018
    Share Share
    Lupin submits fresh studies for two products suspended by EMA
    Lupin submits fresh studies for two products suspended by EMA

    27 May 2015

    // PTI THE ECONOMIC TIMES

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-submits-fresh-studies-for-two-products-suspended-by-ema/articleshow/47428166.cms

    PTI THE ECONOMIC TIMES
    27 May 2015
    Share Share